0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Bio Pharma Buffer Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-8B15891
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Bio Pharma Buffer Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Bio Pharma Buffer Market Report & Forecast 2023-2029

Code: QYRE-Auto-8B15891
Report
November 2023
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Bio Pharma Buffer Market Size

The global Bio Pharma Buffer revenue was US$ 841.4 million in 2022 and is forecast to a readjusted size of US$ 1376.7 million by 2029 with a CAGR of 7.2% during the forecast period (2023-2029).

and India Bio Pharma Buffer Market

and India Bio Pharma Buffer Market

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
In India, the Bio Pharma Buffer revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
This report focuses on global and India Bio Pharma Buffer market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Bio Pharma Buffer will continue to grow rapidly in the future.
Global Bio Pharma Buffer Scope and Market Size
Bio Pharma Buffer market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Bio Pharma Buffer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Bio Pharma Buffer market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Bio Pharma Buffer Market Report

Report Metric Details
Report Name and India Bio Pharma Buffer Market
Forecasted market size in 2029 US$ 1376.7 million
CAGR 7.2%
Forecasted years 2023 - 2029
Segment by Type
  • Phosphates Type
  • Acetates Type
  • TRIS Type
  • Others
Segment by Application
  • Research Institution
  • Pharmaceutical Industry
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Bio Pharma Buffer Market size in 2029?

Ans: The and India Bio Pharma Buffer Market size in 2029 will be US$ 1376.7 million.

What is the market share of major companies in and India Bio Pharma Buffer Market?

Ans: Because the top 6 companies have more than 70% market share.

What is the and India Bio Pharma Buffer Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Bio Pharma Buffer Market report?

Ans: The main players in the and India Bio Pharma Buffer Market are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL

What are the Application segmentation covered in the and India Bio Pharma Buffer Market report?

Ans: The Applications covered in the and India Bio Pharma Buffer Market report are Research Institution, Pharmaceutical Industry, Others

What are the Type segmentation covered in the and India Bio Pharma Buffer Market report?

Ans: The Types covered in the and India Bio Pharma Buffer Market report are Phosphates Type, Acetates Type, TRIS Type, Others

Recommended Reports

Biopharma Manufacturing

Biopharma Packaging

Drug Conjugates & Excipients

1 Study Coverage
1.1 Bio Pharma Buffer Product Introduction
1.2 Global Bio Pharma Buffer Outlook 2018 VS 2022 VS 2029
1.2.1 Global Bio Pharma Buffer Sales in US$ Million for the Year 2018-2029
1.2.2 Global Bio Pharma Buffer Sales in Volume for the Year 2018-2029
1.3 India Bio Pharma Buffer Outlook 2018 VS 2022 VS 2029
1.3.1 India Bio Pharma Buffer Sales in US$ Million for the Year 2018-2029
1.3.2 India Bio Pharma Buffer Sales in Volume for the Year 2018-2029
1.4 Bio Pharma Buffer Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Bio Pharma Buffer in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Bio Pharma Buffer Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Bio Pharma Buffer Market Dynamics
1.5.1 Bio Pharma Buffer Industry Trends
1.5.2 Bio Pharma Buffer Market Drivers
1.5.3 Bio Pharma Buffer Market Challenges
1.5.4 Bio Pharma Buffer Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Bio Pharma Buffer by Type
2.1 Bio Pharma Buffer Market Segment by Type
2.1.1 Phosphates Type
2.1.2 Acetates Type
2.1.3 TRIS Type
2.1.4 Others
2.2 Global Bio Pharma Buffer Market Size by Type
2.2.1 Global Bio Pharma Buffer Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Bio Pharma Buffer Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Bio Pharma Buffer Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Bio Pharma Buffer Market Size by Type
2.3.1 India Bio Pharma Buffer Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Bio Pharma Buffer Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Bio Pharma Buffer Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Bio Pharma Buffer by Application
3.1 Bio Pharma Buffer Market Segment by Application
3.1.1 Research Institution
3.1.2 Pharmaceutical Industry
3.1.3 Others
3.2 Global Bio Pharma Buffer Market Size by Application
3.2.1 Global Bio Pharma Buffer Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Bio Pharma Buffer Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Bio Pharma Buffer Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Bio Pharma Buffer Market Size by Application
3.3.1 India Bio Pharma Buffer Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Bio Pharma Buffer Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Bio Pharma Buffer Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Bio Pharma Buffer Competitor Landscape by Company
4.1 Global Bio Pharma Buffer Market Size by Company
4.1.1 Global Key Manufacturers of Bio Pharma Buffer, Ranked by Revenue (2022)
4.1.2 Global Bio Pharma Buffer Revenue by Manufacturer (2018-2023)
4.1.3 Global Bio Pharma Buffer Sales by Manufacturer (2018-2023)
4.1.4 Global Bio Pharma Buffer Price by Manufacturer (2018-2023)
4.2 Global Bio Pharma Buffer Concentration Ratio (CR)
4.2.1 Bio Pharma Buffer Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Bio Pharma Buffer in 2022
4.2.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Bio Pharma Buffer, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Bio Pharma Buffer, Product Offered and Application
4.5 Global Key Manufacturers of Bio Pharma Buffer, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Bio Pharma Buffer Market Size by Company
4.7.1 Key Players of Bio Pharma Buffer in India, Ranked by Revenue (2022)
4.7.2 India Bio Pharma Buffer Revenue by Players (2018-2023)
4.7.3 India Bio Pharma Buffer Sales by Players (2018-2023)
5 Global Bio Pharma Buffer Market Size by Region
5.1 Global Bio Pharma Buffer Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Bio Pharma Buffer Market Size in Volume by Region (2018-2029)
5.2.1 Global Bio Pharma Buffer Sales in Volume by Region: 2018-2023
5.2.2 Global Bio Pharma Buffer Sales in Volume Forecast by Region (2024-2029)
5.3 Global Bio Pharma Buffer Market Size in Value by Region (2018-2029)
5.3.1 Global Bio Pharma Buffer Sales in Value by Region: 2018-2023
5.3.2 Global Bio Pharma Buffer Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Bio Pharma Buffer Market Size YoY Growth 2018-2029
6.2 Americas Bio Pharma Buffer Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Bio Pharma Buffer Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Bio Pharma Buffer Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Bio Pharma Buffer Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Bio Pharma Buffer Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Bio Pharma Buffer Market Size YoY Growth 2018-2029
7.2 EMEA Bio Pharma Buffer Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Bio Pharma Buffer Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Bio Pharma Buffer Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Bio Pharma Buffer Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Bio Pharma Buffer Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Bio Pharma Buffer Market Size YoY Growth 2018-2029
8.2 China Bio Pharma Buffer Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Bio Pharma Buffer Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Bio Pharma Buffer Market Size YoY Growth 2018-2029
9.2 APAC Bio Pharma Buffer Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Bio Pharma Buffer Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Bio Pharma Buffer Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Bio Pharma Buffer Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Bio Pharma Buffer Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Avantor
10.1.1 Avantor Company Information
10.1.2 Avantor Description and Business Overview
10.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Avantor Bio Pharma Buffer Products Offered
10.1.5 Avantor Recent Development
10.2 Alfa Aesar (Thermo Fisher)
10.2.1 Alfa Aesar (Thermo Fisher) Company Information
10.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
10.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Products Offered
10.2.5 Alfa Aesar (Thermo Fisher) Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Description and Business Overview
10.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Bio Pharma Buffer Products Offered
10.3.5 Merck Recent Development
10.4 Lonza
10.4.1 Lonza Company Information
10.4.2 Lonza Description and Business Overview
10.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lonza Bio Pharma Buffer Products Offered
10.4.5 Lonza Recent Development
10.5 Bio-Rad
10.5.1 Bio-Rad Company Information
10.5.2 Bio-Rad Description and Business Overview
10.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bio-Rad Bio Pharma Buffer Products Offered
10.5.5 Bio-Rad Recent Development
10.6 BD
10.6.1 BD Company Information
10.6.2 BD Description and Business Overview
10.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BD Bio Pharma Buffer Products Offered
10.6.5 BD Recent Development
10.7 GE Healthcare
10.7.1 GE Healthcare Company Information
10.7.2 GE Healthcare Description and Business Overview
10.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GE Healthcare Bio Pharma Buffer Products Offered
10.7.5 GE Healthcare Recent Development
10.8 Promega Corporation
10.8.1 Promega Corporation Company Information
10.8.2 Promega Corporation Description and Business Overview
10.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Promega Corporation Bio Pharma Buffer Products Offered
10.8.5 Promega Corporation Recent Development
10.9 Hamilton Company
10.9.1 Hamilton Company Company Information
10.9.2 Hamilton Company Description and Business Overview
10.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hamilton Company Bio Pharma Buffer Products Offered
10.9.5 Hamilton Company Recent Development
10.10 XZL BIO-TECHNOLOGY
10.10.1 XZL BIO-TECHNOLOGY Company Information
10.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
10.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Products Offered
10.10.5 XZL BIO-TECHNOLOGY Recent Development
10.11 SRL
10.11.1 SRL Company Information
10.11.2 SRL Description and Business Overview
10.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2018-2023)
10.11.4 SRL Bio Pharma Buffer Products Offered
10.11.5 SRL Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Bio Pharma Buffer Industry Chain Analysis
11.2 Bio Pharma Buffer Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Bio Pharma Buffer Production Mode & Process
11.4 Bio Pharma Buffer Sales and Marketing
11.4.1 Bio Pharma Buffer Sales Channels
11.4.2 Bio Pharma Buffer Distributors
11.5 Bio Pharma Buffer Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Bio Pharma Buffer CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Bio Pharma Buffer Market Trends
    Table 3. Bio Pharma Buffer Market Drivers
    Table 4. Bio Pharma Buffer Market Challenges
    Table 5. Bio Pharma Buffer Market Restraints
    Table 6. Global Bio Pharma Buffer Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Bio Pharma Buffer Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Bio Pharma Buffer Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Bio Pharma Buffer Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Bio Pharma Buffer, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Bio Pharma Buffer Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Bio Pharma Buffer Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Bio Pharma Buffer Sales by Manufacturer, (K Liter), 2018-2023
    Table 14. Global Bio Pharma Buffer Sales Share by Manufacturer, 2018-2023
    Table 15. Global Bio Pharma Buffer Price by Manufacturer (2018-2023) & (USD/Liter)
    Table 16. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2022)
    Table 18. Global Key Manufacturers of Bio Pharma Buffer, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Bio Pharma Buffer, Product Offered and Application
    Table 20. Global Key Manufacturers of Bio Pharma Buffer, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Bio Pharma Buffer in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Bio Pharma Buffer Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Bio Pharma Buffer Revenue Share by Players, (2018-2023)
    Table 25. India Bio Pharma Buffer Sales by Players, (K Liter), (2018-2023)
    Table 26. India Bio Pharma Buffer Sales Share by Players, (2018-2023)
    Table 27. Global Bio Pharma Buffer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Bio Pharma Buffer Sales in Volume by Region (2018-2023) & (K Liter)
    Table 29. Global Bio Pharma Buffer Sales in Volume Forecast by Region (2024-2029) & (K Liter)
    Table 30. Global Bio Pharma Buffer Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Bio Pharma Buffer Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Bio Pharma Buffer Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Bio Pharma Buffer Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Bio Pharma Buffer Sales in Volume by Country (2018-2023) & (K Liter)
    Table 36. Americas Bio Pharma Buffer Sales in Volume by Country (2024-2029) & (K Liter)
    Table 37. EMEA Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Bio Pharma Buffer Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Bio Pharma Buffer Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Bio Pharma Buffer Sales in Volume by Country (2018-2023) & (K Liter)
    Table 41. EMEA Bio Pharma Buffer Sales in Volume by Country (2024-2029) & (K Liter)
    Table 42. APAC Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Bio Pharma Buffer Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Bio Pharma Buffer Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Bio Pharma Buffer Sales in Volume by Country (2018-2023) & (K Liter)
    Table 46. APAC Bio Pharma Buffer Sales in Volume by Country (2024-2029) & (K Liter)
    Table 47. Avantor Company Information
    Table 48. Avantor Description and Business Overview
    Table 49. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 50. Avantor Bio Pharma Buffer Product
    Table 51. Avantor Recent Development
    Table 52. Alfa Aesar (Thermo Fisher) Company Information
    Table 53. Alfa Aesar (Thermo Fisher) Description and Business Overview
    Table 54. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 55. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
    Table 56. Alfa Aesar (Thermo Fisher) Recent Development
    Table 57. Merck Company Information
    Table 58. Merck Description and Business Overview
    Table 59. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 60. Merck Bio Pharma Buffer Product
    Table 61. Merck Recent Development
    Table 62. Lonza Company Information
    Table 63. Lonza Description and Business Overview
    Table 64. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 65. Lonza Bio Pharma Buffer Product
    Table 66. Lonza Recent Development
    Table 67. Bio-Rad Company Information
    Table 68. Bio-Rad Description and Business Overview
    Table 69. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 70. Bio-Rad Bio Pharma Buffer Product
    Table 71. Bio-Rad Recent Development
    Table 72. BD Company Information
    Table 73. BD Description and Business Overview
    Table 74. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 75. BD Bio Pharma Buffer Product
    Table 76. BD Recent Development
    Table 77. GE Healthcare Company Information
    Table 78. GE Healthcare Description and Business Overview
    Table 79. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 80. GE Healthcare Bio Pharma Buffer Product
    Table 81. GE Healthcare Recent Development
    Table 82. Promega Corporation Company Information
    Table 83. Promega Corporation Description and Business Overview
    Table 84. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 85. Promega Corporation Bio Pharma Buffer Product
    Table 86. Promega Corporation Recent Development
    Table 87. Hamilton Company Company Information
    Table 88. Hamilton Company Description and Business Overview
    Table 89. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 90. Hamilton Company Bio Pharma Buffer Product
    Table 91. Hamilton Company Recent Development
    Table 92. XZL BIO-TECHNOLOGY Company Information
    Table 93. XZL BIO-TECHNOLOGY Description and Business Overview
    Table 94. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 95. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
    Table 96. XZL BIO-TECHNOLOGY Recent Development
    Table 97. SRL Company Information
    Table 98. SRL Description and Business Overview
    Table 99. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2018-2023)
    Table 100. SRL Bio Pharma Buffer Product
    Table 101. SRL Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Bio Pharma Buffer Customers List
    Table 105. Bio Pharma Buffer Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bio Pharma Buffer Product Picture
    Figure 2. Global Bio Pharma Buffer Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Bio Pharma Buffer Market Size 2018-2029 (US$ Million)
    Figure 4. Global Bio Pharma Buffer Sales 2018-2029 (K Liter)
    Figure 5. India Bio Pharma Buffer Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Bio Pharma Buffer Market Size 2018-2029 (US$ Million)
    Figure 7. India Bio Pharma Buffer Sales 2018-2029 (K Liter)
    Figure 8. India Bio Pharma Buffer Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Bio Pharma Buffer Market Share in Global, in Volume (K Liter) 2018-2029
    Figure 10. Bio Pharma Buffer Report Years Considered
    Figure 11. Product Picture of Phosphates Type
    Figure 12. Product Picture of Acetates Type
    Figure 13. Product Picture of TRIS Type
    Figure 14. Product Picture of Others
    Figure 15. Global Bio Pharma Buffer Market Share by Type in 2022 & 2029
    Figure 16. Global Bio Pharma Buffer Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 17. Global Bio Pharma Buffer Sales Market Share in Value by Type (2018-2029)
    Figure 18. Global Bio Pharma Buffer Sales by Type (2018-2029) & (K Liter)
    Figure 19. Global Bio Pharma Buffer Sales Market Share in Volume by Type (2018-2029)
    Figure 20. Global Bio Pharma Buffer Price by Type (2018-2029) & (USD/Liter)
    Figure 21. India Bio Pharma Buffer Market Share by Type in 2022 & 2029
    Figure 22. India Bio Pharma Buffer Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 23. India Bio Pharma Buffer Sales Market Share in Value by Type (2018-2029)
    Figure 24. India Bio Pharma Buffer Sales by Type (2018-2029) & (K Liter)
    Figure 25. India Bio Pharma Buffer Sales Market Share in Volume by Type (2018-2029)
    Figure 26. India Bio Pharma Buffer Price by Type (2018-2029) & (USD/Liter)
    Figure 27. Product Picture of Research Institution
    Figure 28. Product Picture of Pharmaceutical Industry
    Figure 29. Product Picture of Others
    Figure 30. Global Bio Pharma Buffer Market Share by Application in 2022 & 2029
    Figure 31. Global Bio Pharma Buffer Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Bio Pharma Buffer Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Bio Pharma Buffer Sales by Application (2018-2029) & (K Liter)
    Figure 34. Global Bio Pharma Buffer Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Bio Pharma Buffer Price by Application (2018-2029) & (USD/Liter)
    Figure 36. India Bio Pharma Buffer Market Share by Application in 2022 & 2029
    Figure 37. India Bio Pharma Buffer Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Bio Pharma Buffer Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Bio Pharma Buffer Sales by Application (2018-2029) & (K Liter)
    Figure 40. India Bio Pharma Buffer Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Bio Pharma Buffer Price by Application (2018-2029) & (USD/Liter)
    Figure 42. Americas Bio Pharma Buffer Sales in Volume Growth Rate 2018-2029 (K Liter)
    Figure 43. Americas Bio Pharma Buffer Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Bio Pharma Buffer Sales by Type (2018-2029) & (K Liter)
    Figure 45. Americas Bio Pharma Buffer Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Bio Pharma Buffer Sales by Application (2018-2029) & (K Liter)
    Figure 47. Americas Bio Pharma Buffer Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Bio Pharma Buffer Sales in Volume Growth Rate 2018-2029 (K Liter)
    Figure 53. EMEA Bio Pharma Buffer Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Bio Pharma Buffer Sales by Type (2018-2029) & (K Liter)
    Figure 55. EMEA Bio Pharma Buffer Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Bio Pharma Buffer Sales by Application (2018-2029) & (K Liter)
    Figure 57. EMEA Bio Pharma Buffer Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Bio Pharma Buffer Sales in Volume Growth Rate 2018-2029 (K Liter)
    Figure 62. China Bio Pharma Buffer Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Bio Pharma Buffer Sales by Type (2018-2029) & (K Liter)
    Figure 64. China Bio Pharma Buffer Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Bio Pharma Buffer Sales by Application (2018-2029) & (K Liter)
    Figure 66. China Bio Pharma Buffer Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Bio Pharma Buffer Sales in Volume Growth Rate 2018-2029 (K Liter)
    Figure 68. APAC Bio Pharma Buffer Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Bio Pharma Buffer Sales by Type (2018-2029) & (K Liter)
    Figure 70. APAC Bio Pharma Buffer Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Bio Pharma Buffer Sales by Application (2018-2029) & (K Liter)
    Figure 72. APAC Bio Pharma Buffer Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Bio Pharma Buffer Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Bio Pharma Buffer Value Chain
    Figure 79. Bio Pharma Buffer Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Automatic Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8S20198
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Optically Clear PCR Strip Tubes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1L20132
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Avena Sativa Kernel Meal Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28Q19902
Tue Dec 02 00:00:00 UTC 2025

Add to Cart